Los puntos clave no están disponibles para este artículo en este momento.
Early evidence suggests that the RACE Act was effective at closing the loopholes of previous legislation and creating new opportunities for innovation in developing therapies for childhood cancers.
Marjorie E. Zettler (Thu,) studied this question.